Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
暂无分享,去创建一个
S. Connolly | J. Weitz | H. Kastrissios | S. Rohatagi | J. Mendell | D. Salazar | S. Kunitada | Indravadan Patel | Jianqing Jin